Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, 97006, USA.
Am J Physiol Endocrinol Metab. 2010 Sep;299(3):E486-96. doi: 10.1152/ajpendo.00330.2010. Epub 2010 Jun 22.
Increased body fat correlates with the enlargement of average fat cell size and reduced adipose tissue insulin sensitivity. It is currently unclear whether adipocytes, as they accumulate more triglycerides and grow in size, gradually become less insulin sensitive or whether obesity-related factors independently cause both the enlargement of adipocyte size and reduced adipose tissue insulin sensitivity. In the first instance, large and small adipocytes in the same tissue would exhibit differences in insulin sensitivity, whereas, in the second instance, adipocyte size per se would not necessarily correlate with insulin response. To analyze the effect of adipocyte size on insulin sensitivity, we employed a new single-cell imaging assay that resolves fatty acid uptake and insulin response in single adipocytes in subcutaneous adipose tissue explants. Here, we report that subcutaneous adipocytes are heterogeneous in size and intrinsic insulin sensitivity. Whereas smaller adipocytes respond to insulin by increasing lipid uptake, adipocytes with cell diameters larger than 80-100 microm are insulin resistant. We propose that, when cell size approaches a critical boundary, adipocytes lose insulin-dependent fatty acid transport. This negative feedback mechanism may protect adipocytes from lipid overload and restrict further expansion of adipose tissue, which leads to obesity and metabolic complications.
体内脂肪的增加与平均脂肪细胞大小的增大和脂肪组织胰岛素敏感性的降低有关。目前尚不清楚脂肪细胞在积累更多甘油三酯和增大体积的过程中,是逐渐变得对胰岛素不敏感,还是肥胖相关因素独立导致脂肪细胞大小的增大和脂肪组织胰岛素敏感性的降低。在第一种情况下,同一组织中的大和小的脂肪细胞在胰岛素敏感性上会表现出差异,而在第二种情况下,脂肪细胞大小本身不一定与胰岛素反应相关。为了分析脂肪细胞大小对胰岛素敏感性的影响,我们采用了一种新的单细胞成像测定法,该方法可以解析皮下脂肪组织外植体中单个脂肪细胞的脂肪酸摄取和胰岛素反应。在这里,我们报告说,皮下脂肪细胞在大小和内在胰岛素敏感性上存在异质性。较小的脂肪细胞通过增加脂质摄取对胰岛素产生反应,而直径大于 80-100 微米的脂肪细胞对胰岛素产生抵抗。我们提出,当细胞大小接近临界边界时,脂肪细胞会失去胰岛素依赖性脂肪酸转运。这种负反馈机制可以保护脂肪细胞免受脂质过载的影响,并限制脂肪组织的进一步扩张,从而导致肥胖和代谢并发症。